Idiopathic acute liver injury in paediatric outpatients: Incidence and signal detection in two european countries

Drug Safety

Volumn 36, Issue 10, 2013, Pages 1007-1016

  Ferrajolo, Carmen ^a,b   Verhamme, Katia M C ^b   Trifirò, Gianluca ^b,c   'T Jong, Geert W ^b,d   Giaquinto, Carlo ^e   Picelli, Gino ^f   Oteri, Alessandro ^b   De Bie, Sandra ^b   Valkhoff, Vera E ^b   Schuemie, Martijn J ^b   Mazzaglia, Giampiero ^g   Cricelli, Claudio ^g   Rossi, Francesco ^a   Capuano, Annalisa ^a   Sturkenboom, Miriam C J M ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF MESSINA   (Italy)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^f Pedianet Societa' Servizi Telematici SRL   (Italy)

^g Societa Italiana di Medicina Generale   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CARBAMAZEPINE; CLARITHROMYCIN; COTRIMOXAZOLE; ISONIAZID PLUS RIFAMPICIN; KETOPROFEN; PARACETAMOL; PHENOBARBITAL; ROKITAMYCIN; VALPROIC ACID;

ABNORMAL LABORATORY RESULT; ACUTE LIVER FAILURE; ADOLESCENT; ARTICLE; CHILD; CHILD HEALTH CARE; CLINICAL FEATURE; COHORT ANALYSIS; COMPUTER PROGRAM; DATA BASE; DATA MINING; DISEASE SEVERITY; DRUG INDUCED DISEASE; DRUG USE; ELECTRONIC MEDICAL RECORD; EUROPE; FATTY LIVER; FEMALE; GENERAL PRACTICE; HEPATOMEGALY; HUMAN; IDIOPATHIC DISEASE; INCIDENCE; INFANT; ITALY; LIVER FUNCTION TEST; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NEWBORN; OUTPATIENT; POPULATION RESEARCH; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SIGNAL DETECTION; TOXIC HEPATITIS;

ADOLESCENT; AMBULATORY CARE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DATABASES, FACTUAL; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; ITALY; LIVER FAILURE, ACUTE; MALE; NETHERLANDS; RETROSPECTIVE STUDIES;

EID: 84885452246     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.1007/s40264-013-0045-7     Document Type: Article

References (43)

1. Narkewicz MR, Dell Olio D, Karpen SJ, et al. Pattern of diagnostic evaluation for the causes of pediatric acute liver failure: an opportunity for quality improvement. J Pediatr. 2009;155:801-6.e1.
2. Fontana RJ, Seeff LB, Andrade RJ, et al. Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology (Baltimore). 2010;52:730-42.
3. De Valle MB, Av Klinteberg V, Alem N, et al. Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic. Aliment Pharmacol Ther. 2006;24:1187-95.
4. Andrade RJ, Lucena MI, Fernandez MC, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology. 2005;129:512-21.
5. Molleston JP, Fontana RJ, Lopez MJ, et al. Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study. J Pediatr Gastroenterol Nutr. 2011;53:182-9.
6. Trifiro G, Pariente A, Coloma PM, et al. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor? Pharmacoepidemiol Drug Saf. 2009;18:1176-84.
7. Schwimmer JB, Deutsch R, Kahen T, et al. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118:1388-93.
8. Cricelli C, Mazzaglia G, Samani F, et al. Prevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databases. J Public Health Med. 2003;25:254-7.
9. Mazzaglia G, Mantovani LG, Sturkenboom MC, et al. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens. 2005;23:2093-100.
10. Neubert A, Verhamme K, Murray ML, et al. The prescribing of analgesics and non-steroidal anti-inflammatory drugs in paediatric primary care in the UK, Italy and The Netherlands. Pharmacol Res. 2010;62:243-8.
11. Sen EF, Verhamme KM, Neubert A, et al. Assessment of pediatric asthma drug use in three European countries; a TEDDY study. Eur J Pediatr. 2011;170:81-92.
12. Sturkenboom MC, Verhamme KM, Nicolosi A, et al. Drug use in children: cohort study in three European countries. BMJ (Clin Res Edn.) 2008;337:a2245.
13. van Soest EM, Valkhoff VE, Mazzaglia G, et al. Suboptimal gastroprotective coverage of NSAID use and the risk of upper gastrointestinal bleeding and ulcers: an observational study using three European databases. Gut. 2011;60(12):1650-9.
14. Charlton M, Angulo P, Chalasani N, et al. Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease. Hepatology (Baltimore). 2008;47:484-92.
15. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an international consensus meeting. Int J Clin Pharmacol Ther Toxicol. 1990;28:317-22.
16. Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol. 1990;11:272-6.
17. de Abajo FJ, Montero D, Madurga M, et al. Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br J Clin Pharmacol. 2004;58:71-80.
18. Duh MS, Walker AM, Kronlund KH Jr. Descriptive epidemiology of acute liver enzyme abnormalities in the general population of central Massachusetts. Pharmacoepidemiol Drug Saf. 1999;8:275-83.
19. Lucena MI, Garcia-Cortes M, Cueto R, et al. Assessment of drug-induced liver injury in clinical practice. Fundam Clin Pharmacol. 2008;22:141-58.
20. Traversa G, Bianchi C, Da Cas R, et al. Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs. BMJ (Clin Res Edn). 2003;327:18-22.
21. Suzuki A, Brunt EM, Kleiner DE, et al. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology (Baltimore). 2011;54:931-9.
22. Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med. 2006;354:731-9.
23. Coloma PM, Schuemie MJ, Trifiro G, et al. Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project. Pharmacoepidemiol Drug Saf. 2011;20:1-11.
24. Schuemie MJ. Methods for drug safety signal detection in longitudinal observational databases: LGPS and LEOPARD. Pharmacoepidemiol Drug Saf. 2011;20:292-9.
25. Trifiro G, Patadia V, Schuemie MJ, et al. EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection. Stud Health Technol Inform. 2011;166:25-30.
26. Bell LN, Chalasani N. Epidemiology of idiosyncratic drug-induced liver injury. Semin Liver Dis. 2009;29:337-47.
27. Hussaini SH, O'Brien CS, Despott EJ, et al. Antibiotic therapy: a major cause of drug-induced jaundice in southwest England. Eur J Gastroenterol Hepatol. 2007;19:15-20.
28. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137:947-54.
29. Sgro C, Clinard F, Ouazir K, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology (Baltimore) 2002;36:451-5.
30. Nicastro E, Ranucci G, Vajro P, et al. Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease. Hepatology (Baltimore) 2010;52:1948-56.
31. Ferrajolo C, Capuano A, Verhamme KM, et al. Drug-induced hepatic injury in children: a case/non-case study of suspected adverse drug reactions in VigiBase. Br J Clin Pharmacol. 2010;70:721-8.
32. Hines RN. The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacol Ther. 2008;118:250-67.
33. Murray KF, Hadzic N, Wirth S, et al. Drug-related hepatotoxicity and acute liver failure. J Pediatr Gastroenterol Nutr. 2008;47:395-405.
34. Pineiro-Carrero VM, Pineiro EO. Liver. Pediatrics. 2004;113:1097-106.
35. Garcia Rodriguez LA, Stricker BH, Zimmerman HJ. Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid. Arch Intern Med. 1996;156:1327-32.
36. Salvo F, Polimeni G, Moretti U, et al. Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy. J Antimicrob Chemother. 2007;60:121-6.
37. Lucena MI, Molokhia M, Shen Y, et al. Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology. 2011;141:338-47.
38. Cuzzolin L, Antonucci R, Fanos V. Paracetamol (Acetaminophen) Efficacy and Safety in the Newborn. Curr Drug Metabol. 2012;14(2):178-85.
39. Observational Medical Outcomes Partnership (OMOP). Available from URL: http://omop.fnih.org. Accessed 23 Feb 2011.
40. Chan DF, Li AM, Chu WC, et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord. 2004;28:1257-63.
41. Nobili V, Marcellini M, Devito R, et al. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology (Baltimore). 2006;44:458-65.
42. Rashid M, Roberts EA. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 2000;30:48-53.
43. Schwimmer JB, Behling C, Newbury R, et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology (Baltimore). 2005;42:641-9.